Sutro Biopharma: First Quarter Financial Results, Business Highlights and More

Sutro Biopharma Inc
Sutro Biopharma (STRO) is a clinical-stage drug discovery, development and manufacturing company. Its expertise is in the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics.

Sutro Biopharma reported its financial results for the first quarter of 2021 and its recent business highlights, in addition to providing a preview of anticipated selected . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.